In vitro activity of linezolid against clinical isolates of methicillin resistant Staphylococcus (original) (raw)

In-vitro activity of Linezolid and other antimicrobial agents against methicillin resistant staphylococci

Abdulaziz Zorgani

View PDFchevron_right

In-vitro susceptibility of linezolid against methicillin resistant Staphylococcus aureus at a tertiary care hospital in Pakistan

Ali Irfan Khalid

Journal of Microbiology and Infectious Diseases

View PDFchevron_right

Detection of in-vitro Activity of Linezolid in Methicillin Resistant Staphylococcus aureus Infections by E-test

Smitha Bagali

2015

View PDFchevron_right

In vitro activity of linezolid against clinical Gram-positive bacterial isolates from Taiwan: an area with a high prevalence of antibiotic resistance

Abdul Hannan

International Journal of Antimicrobial Agents, 2001

View PDFchevron_right

An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy

Richard Watkins

Core Evidence, 2012

View PDFchevron_right

European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid

Matthew Dryden

Clinical Microbiology and Infection, 2014

View PDFchevron_right

PP-004 Comparison of in vitro efficacy of linezolid, tigecycline and chloramphenicol against methicillin resistant Staphylococcus aureus (MRSA) isolated from tertiary care hospital of Pakistan

Ali Irfan Khalid

International Journal of Infectious Diseases, 2010

View PDFchevron_right

The emerging problem of linezolid-resistant Staphylococcus

Sotirios Tsiodras

Journal of Antimicrobial Chemotherapy, 2012

View PDFchevron_right

In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus

Jose Arce

View PDFchevron_right

methicillin-resistant Staphylococcus

Anne Missavage

2014

View PDFchevron_right

In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods

Jocelyne Caillon, Cédric Jacqueline, Gilles Potel

2003

View PDFchevron_right

PP-002 Comparison of in vitro efficacy of linezolid and vancomycin against methicillin resistant Staphylococcus aureus (MRSA)

Ali Irfan Khalid

International Journal of Infectious Diseases, 2010

View PDFchevron_right

Linezolid resistance in clinical isolates of Staphylococcus aureus

Ortrud Zimmermann

Journal of Antimicrobial Chemotherapy, 2003

View PDFchevron_right

Clinical and Microbiological Effect of Linezolid on Methicillin-Resistant Staphylococcus aureus (MRSA) Colonization in Healthcare Workers in Egypt

Noha Gamal

View PDFchevron_right

Linezolid Alone or Combined with Rifampin against Methicillin-Resistant Staphylococcus aureus in Experimental Foreign-Body Infection

Daniela Baldoni

Antimicrobial Agents and Chemotherapy, 2009

View PDFchevron_right

Resistance to linezolid in a methicillin-susceptible Staphylococcus aureus clinical isolate without previous exposure to oxazolidinones

Jesús Mingorance

View PDFchevron_right

Intra- and extracellular activity of linezolid against Staphylococcus aureus in vivo and in vitro

Niels Frimodt-møller

Journal of Antimicrobial Chemotherapy, 2010

View PDFchevron_right

Emergence of Linezolid Resistance in a Methicillin Resistant Staphylococcus aureus Strain

H. Rohde, Martin Aepfelbacher

Infection, 2008

View PDFchevron_right

In vitro susceptibility to methicillin, vancomycin and linezolid of staphylococci isolated from bloodstream infections in eastern Turkey

Ali Cem Tekin

Brazilian Journal of Microbiology, 2014

View PDFchevron_right

Efficacy of Linezolid in Treatment of Experimental Endocarditis Caused by Methicillin-Resistant Staphylococcus aureus

john gibson

Antimicrobial Agents and Chemotherapy, 2001

View PDFchevron_right

In Vitro and In Vivo Assessment of Linezolid Combined with Ertapenem: a Highly Synergistic Combination against Methicillin-Resistant Staphylococcus aureus

Caillon J, Jocelyne Caillon, Cédric Jacqueline, Gilles Potel

Antimicrobial Agents and Chemotherapy, 2006

View PDFchevron_right

In Vitro Bactericidal Activities of Linezolid in Combination with Vancomycin, Gentamicin, Ciprofloxacin, Fusidic Acid, and Rifampin against Staphylococcus aureus

M. Kitzis, P. Grohs

Antimicrobial Agents and Chemotherapy, 2003

View PDFchevron_right

Efficacy of linezolid against Staphylococcus aureus in different rodent skin and soft tissue infections models

Dilip Upadhyay

Microbiology Research, 2011

View PDFchevron_right

Comparison of in vitro efficacy of linezolid and vancomycin by determining their minimum inhibitory concentrations against methicillin resistant Staphylococcus aureus (MRSA)

Fatima Kaleem

JPMA. The Journal of the Pakistan Medical Association, 2011

View PDFchevron_right

Inhibition of biofilm maturation by linezolid in meticillin-resistant Staphylococcus epidermidis clinical isolates: comparison with other drugs

Bárbara Villa

Journal of medical microbiology, 2013

View PDFchevron_right

In vitro activity of fosfomycin in combination with linezolid against clinical isolates of methicillin-resistant Staphylococcus aureus

Drosos Karageorgopoulos

The Journal of Antibiotics, 2014

View PDFchevron_right

Mechanisms of Linezolid Resistance among Staphylococci in a Tertiary Hospital

Jesús Mingorance

View PDFchevron_right

Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus

Matthew Dryden

The American Journal of Surgery, 2010

View PDFchevron_right

Linezolid Resistance in Staphylococci

Floriana Campanile

Pharmaceuticals, 2010

View PDFchevron_right

In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates from skin and soft tissue infections to vancomycin, daptomycin, linezolid, and tedizolid

Judy Natalia Jiménez-Quiceno

The Brazilian Journal of Infectious Diseases, 2017

View PDFchevron_right

In Vitro and In Vivo Synergistic Activities of Linezolid Combined with Subinhibitory Concentrations of Imipenem against Methicillin-Resistant Staphylococcus aureus

Caillon J, Jocelyne Caillon, Cédric Jacqueline, Gilles Potel

Antimicrobial Agents and Chemotherapy, 2005

View PDFchevron_right

In vitro activity of linezolid against clinical isolates of Fusobacterium spp

Ojan Assadian

Journal of Antimicrobial Chemotherapy, 2006

View PDFchevron_right

Low Prevalence of Cfr-Mediated Linezolid Resistance among Methicillin-Resistant Staphylococcus aureus in a Spanish Hospital: Case Report on Linezolid Resistance Acquired during Linezolid Therapy

Josep M. Sierra, Miquel Pujol

PLoS ONE, 2013

View PDFchevron_right

Linezolid and its derivatives: the promising therapeutic challenge to multidrug-resistant pathogens

Luana Calabrone

2018

View PDFchevron_right